Company profile
Solventum Corp
NYSE:SOLVMedical/Dental Instruments
Drug pipeline (4)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| Alcohol | approved | — | 1 | approved |
| Chlorhexidine Gluconate | approved | — | 7 | approved |
| IODINE POVACRYLEX | approved | — | 0 | — |
| Isopropyl alcohol | approved | — | 0 | — |
Revenue is the latest reported period from SEC filings. A combination product's amount appears on each of its constituent assets, so those rows are not additive.
Clinical trials (16)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04601103 | — | terminated | 2020-01-06 | 2020-03-10 | Solventum US LLC | 3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes |
| NCT00731042 | phase4 | completed | 2008-03-01 | 2008-04-01 | Solventum US LLC | A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects |
| NCT00516906 | phase2_3 | completed | 2007-10-01 | 2007-12-01 | Solventum US LLC | Clinical Performance of a Chlorhexidine Antimicrobial Dressing |
| NCT01290978 | phase4 | completed | 2010-02-01 | 2010-03-01 | Solventum US LLC | Compare Effect of Surgical Antiseptic Preparations on Incise Drape Adhesion to Skin |
| NCT03155204 | — | completed | 2017-04-25 | 2018-01-21 | Solventum US LLC | Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With A Reference Product |
FDA applications (4)
| Application | Type | Applicant | Products | |||
|---|---|---|---|---|---|---|
| NDA 019028 | NDA | SOLVENTUM US LLC | ||||
Loading… | ||||||
| NDA 021074 | NDA | SOLVENTUM US LLC | ||||
Loading… | ||||||
| NDA 021586 | NDA | SOLVENTUM US LLC | ||||
Loading… | ||||||
| NDA 208288 | NDA | SOLVENTUM US LLC | ||||
Loading… | ||||||